Untargeted Antifungal Treatment in Nonneutropenic Critically Ill Patients: Should Further Studies Be Performed Based on Trial Sequential Analysis Results?
作者信息
Cortegiani Andrea, Giarratano Antonino
机构信息
Department of Biopathology and Medical Biotechnologies (DIBIMED), Section of Anesthesia Analgesia, Intensive Care, and Emergency, Policlinico Paolo Giaccone, University of Palermo, Palermo, Italy
Department of Biopathology and Medical Biotechnologies (DIBIMED), Section of Anesthesia Analgesia, Intensive Care, and Emergency, Policlinico Paolo Giaccone, University of Palermo, Palermo, Italy.
出版信息
Antimicrob Agents Chemother. 2018 Jun 26;62(7). doi: 10.1128/AAC.00810-18. Print 2018 Jul.
Abstract
摘要
相似文献
1
Untargeted Antifungal Treatment in Nonneutropenic Critically Ill Patients: Should Further Studies Be Performed Based on Trial Sequential Analysis Results?非中性粒细胞减少的重症患者的非靶向抗真菌治疗：是否应根据序贯试验分析结果开展进一步研究？
Antimicrob Agents Chemother. 2018 Jun 26;62(7). doi: 10.1128/AAC.00810-18. Print 2018 Jul.
2
Reply to Cortegiani and Giarratano, "Untargeted Antifungal Treatment in Nonneutropenic Critically Ill Patients: Should Further Studies Be Performed Based on Trial Sequential Analysis Results?".对科尔泰贾尼和贾拉塔诺的回复，“非中性粒细胞减少的重症患者的非靶向抗真菌治疗：是否应根据序贯试验分析结果进行进一步研究？”
Antimicrob Agents Chemother. 2018 Jun 26;62(7). doi: 10.1128/AAC.00891-18. Print 2018 Jul.
3
Antifungal agents for preventing fungal infections in non-neutropenic critically ill patients.用于预防非中性粒细胞减少的重症患者真菌感染的抗真菌药物。
Cochrane Database Syst Rev. 2016 Jan 16;2016(1):CD004920. doi: 10.1002/14651858.CD004920.pub3.
4
Choosing Optimal Antifungal Agents To Prevent Fungal Infections in Nonneutropenic Critically Ill Patients: Trial Sequential Analysis, Network Meta-analysis, and Pharmacoeconomic Analysis.选择最佳抗真菌药物预防非中性粒细胞减少危重症患者真菌感染：试验序贯分析、网络荟萃分析和药物经济学分析。
Antimicrob Agents Chemother. 2017 Nov 22;61(12). doi: 10.1128/AAC.00620-17. Print 2017 Dec.
5
Antifungal agents for preventing fungal infections in non-neutropenic critically ill and surgical patients: systematic review and meta-analysis of randomized clinical trials.用于预防非中性粒细胞减少的重症患者和外科手术患者真菌感染的抗真菌药物：随机临床试验的系统评价和荟萃分析
J Antimicrob Chemother. 2006 Apr;57(4):628-38. doi: 10.1093/jac/dki491. Epub 2006 Feb 3.
6
Antifungal agents for preventing fungal infections in non-neutropenic critically ill patients.用于预防非中性粒细胞减少的重症患者真菌感染的抗真菌药物。
Cochrane Database Syst Rev. 2006 Jan 25(1):CD004920. doi: 10.1002/14651858.CD004920.pub2.
7
Development and validation of a risk model for identification of non-neutropenic, critically ill adult patients at high risk of invasive Candida infection: the Fungal Infection Risk Evaluation (FIRE) Study.开发和验证一种风险模型，用于识别非中性粒细胞减少、危重症成年患者侵袭性念珠菌感染的高危人群：真菌感染风险评估（FIRE）研究。
Health Technol Assess. 2013 Feb;17(3):1-156. doi: 10.3310/hta17030.
8
Performance of existing clinical scores and laboratory tests for the diagnosis of invasive candidiasis in critically ill, nonneutropenic, adult patients: A systematic review with qualitative evidence synthesis.现有临床评分和实验室检测在诊断重症、非中性粒细胞减少、成年患者侵袭性念珠菌病中的应用：一项系统评价及定性证据综合分析。
Mycoses. 2022 Dec;65(12):1073-1111. doi: 10.1111/myc.13515. Epub 2022 Sep 4.
9
Intensive care medicine research agenda on invasive fungal infection in critically ill patients.重症患者侵袭性真菌感染的重症监护医学研究议程。
Intensive Care Med. 2017 Sep;43(9):1225-1238. doi: 10.1007/s00134-017-4731-2. Epub 2017 Mar 2.
10
EPICO 3.0. Empirical antifungal therapy in critically-ill hematology patients.EPICO 3.0。危重症血液病患者的经验性抗真菌治疗。
Rev Iberoam Micol. 2016 Oct-Dec;33(4):206-215. doi: 10.1016/j.riam.2016.06.002. Epub 2016 Oct 15.
引用本文的文献
1
Reply to Cortegiani and Giarratano, "Untargeted Antifungal Treatment in Nonneutropenic Critically Ill Patients: Should Further Studies Be Performed Based on Trial Sequential Analysis Results?".对科尔泰贾尼和贾拉塔诺的回复，“非中性粒细胞减少的重症患者的非靶向抗真菌治疗：是否应根据序贯试验分析结果进行进一步研究？”
Antimicrob Agents Chemother. 2018 Jun 26;62(7). doi: 10.1128/AAC.00891-18. Print 2018 Jul.
本文引用的文献
1
Choosing Optimal Antifungal Agents To Prevent Fungal Infections in Nonneutropenic Critically Ill Patients: Trial Sequential Analysis, Network Meta-analysis, and Pharmacoeconomic Analysis.选择最佳抗真菌药物预防非中性粒细胞减少危重症患者真菌感染：试验序贯分析、网络荟萃分析和药物经济学分析。
Antimicrob Agents Chemother. 2017 Nov 22;61(12). doi: 10.1128/AAC.00620-17. Print 2017 Dec.
2
When is a meta-analysis conclusive? A guide to Trial Sequential Analysis with an example of remote ischemic preconditioning for renoprotection in patients undergoing cardiac surgery.荟萃分析何时具有结论性？序贯试验分析指南，并以心脏手术患者肾保护的远程缺血预处理为例
Nephrol Dial Transplant. 2017 Apr 1;32(suppl_2):ii23-ii30. doi: 10.1093/ndt/gfw219.
3
Trial Sequential Analysis in systematic reviews with meta-analysis.系统评价与Meta分析中的序贯试验分析。
BMC Med Res Methodol. 2017 Mar 6;17(1):39. doi: 10.1186/s12874-017-0315-7.
4
Associations of Antifungal Treatments With Prevention of Fungal Infection in Critically Ill Patients Without Neutropenia.抗真菌治疗与非中性粒细胞减少危重症患者真菌感染预防的关联。
JAMA. 2017 Jan 17;317(3):311-312. doi: 10.1001/jama.2016.16535.
5
Antifungal agents for preventing fungal infections in non-neutropenic critically ill patients.用于预防非中性粒细胞减少的重症患者真菌感染的抗真菌药物。
Cochrane Database Syst Rev. 2016 Jan 16;2016(1):CD004920. doi: 10.1002/14651858.CD004920.pub3.
Zotero 插件